↓ Skip to main content

SARS-CoV-2 and EBV; the cost of a second mitochondrial “whammy”?

Overview of attention for article published in Immunity & Ageing, October 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#14 of 452)
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news
1 news outlet
blogs
1 blog
policy
1 policy source
twitter
124 X users

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
48 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
SARS-CoV-2 and EBV; the cost of a second mitochondrial “whammy”?
Published in
Immunity & Ageing, October 2021
DOI 10.1186/s12979-021-00252-x
Pubmed ID
Authors

Alistair V.W. Nunn, Geoffrey W. Guy, Stanley W. Botchway, Jimmy D. Bell

X Demographics

X Demographics

The data shown below were collected from the profiles of 124 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 48 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 48 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 7 15%
Other 5 10%
Researcher 5 10%
Student > Ph. D. Student 3 6%
Librarian 2 4%
Other 6 13%
Unknown 20 42%
Readers by discipline Count As %
Medicine and Dentistry 10 21%
Biochemistry, Genetics and Molecular Biology 4 8%
Immunology and Microbiology 2 4%
Nursing and Health Professions 2 4%
Arts and Humanities 1 2%
Other 5 10%
Unknown 24 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 91. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 April 2024.
All research outputs
#473,811
of 25,761,363 outputs
Outputs from Immunity & Ageing
#14
of 452 outputs
Outputs of similar age
#11,609
of 444,906 outputs
Outputs of similar age from Immunity & Ageing
#1
of 8 outputs
Altmetric has tracked 25,761,363 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 452 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.9. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 444,906 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 8 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them